OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
Josep M. Piulats, Claire Watkins, Marcel Costa-García, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 317-326
Open Access | Times Cited: 17
Josep M. Piulats, Claire Watkins, Marcel Costa-García, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 317-326
Open Access | Times Cited: 17
Showing 17 citing articles:
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115153-115153
Open Access | Times Cited: 9
Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115153-115153
Open Access | Times Cited: 9
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
Joseph J. Sacco, Richard D. Carvajal, Marcus O. Butler, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009028-e009028
Open Access | Times Cited: 6
Joseph J. Sacco, Richard D. Carvajal, Marcus O. Butler, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009028-e009028
Open Access | Times Cited: 6
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma
Robin Reschke, Alexander Enk, Jessica C. Hassel
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1046-1046
Open Access | Times Cited: 6
Robin Reschke, Alexander Enk, Jessica C. Hassel
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1046-1046
Open Access | Times Cited: 6
Targeted therapy in ophthalmic oncology: The current status
Mrittika Sen, Hakan Demirci, Santosh G Honavar
Asia-Pacific Journal of Ophthalmology (2024) Vol. 13, Iss. 2, pp. 100062-100062
Open Access | Times Cited: 5
Mrittika Sen, Hakan Demirci, Santosh G Honavar
Asia-Pacific Journal of Ophthalmology (2024) Vol. 13, Iss. 2, pp. 100062-100062
Open Access | Times Cited: 5
Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E-Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations
Na Zhang, Yu-Wei Qiao, Dan Su, et al.
Clinical Drug Investigation (2025)
Closed Access
Na Zhang, Yu-Wei Qiao, Dan Su, et al.
Clinical Drug Investigation (2025)
Closed Access
Severe Anemia Is an Independent Risk Factor for In-Hospital Death in Persons Living with HIV in Southern China: A Retrospective Cohort Study
Yu Lan, Zhiman Xie, Qin Cao, et al.
AIDS Research and Human Retroviruses (2025)
Closed Access
Yu Lan, Zhiman Xie, Qin Cao, et al.
AIDS Research and Human Retroviruses (2025)
Closed Access
Uveal Melanoma: Molecular Pathology
Sarah E. Coupland, Helen Kalirai, Sophie Thornton, et al.
Clinical ophthalmic oncology (2025), pp. 115-124
Closed Access
Sarah E. Coupland, Helen Kalirai, Sophie Thornton, et al.
Clinical ophthalmic oncology (2025), pp. 115-124
Closed Access
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Elias A. T. Koch, Markus V. Heppt, Carola Berking
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 5, pp. 691-700
Open Access | Times Cited: 3
Elias A. T. Koch, Markus V. Heppt, Carola Berking
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 5, pp. 691-700
Open Access | Times Cited: 3
Immunology of Ocular Tumors
Martine J. Jager, Sen Ma, Elisabet de los Pinos, et al.
Clinical ophthalmic oncology (2025), pp. 73-80
Closed Access
Martine J. Jager, Sen Ma, Elisabet de los Pinos, et al.
Clinical ophthalmic oncology (2025), pp. 73-80
Closed Access
Ocular cancer—Current and new drug delivery systems
Mudassir Ansari, Ujwala Shinde, Kavita Singh
Elsevier eBooks (2025), pp. 451-472
Closed Access
Mudassir Ansari, Ujwala Shinde, Kavita Singh
Elsevier eBooks (2025), pp. 451-472
Closed Access
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Elias A. T. Koch, Anne Petzold, Edgar Dippel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Elias A. T. Koch, Anne Petzold, Edgar Dippel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Recent Advances in Molecular and Genetic Research on Uveal Melanoma
Aurélie Fuentes-Rodriguez, Andrew Mitchell, Sylvain L. Guérin, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1023-1023
Open Access | Times Cited: 1
Aurélie Fuentes-Rodriguez, Andrew Mitchell, Sylvain L. Guérin, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1023-1023
Open Access | Times Cited: 1
Behandlung des metastasierten Melanoms
Georg Lodde, Robin Tamara Eisenburger, Dirk Schadendorf
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 06, pp. 370-375
Closed Access | Times Cited: 1
Georg Lodde, Robin Tamara Eisenburger, Dirk Schadendorf
TumorDiagnostik & Therapie (2024) Vol. 45, Iss. 06, pp. 370-375
Closed Access | Times Cited: 1
Häufigster okkulärer Tumor des Erwachsenen: Diagnostik und Therapie des Aderhautmelanoms
Sebastian Ochsenreither, M. de Bucourt, Oliver Zeitz, et al.
Trillium Krebsmedizin (2024) Vol. 33, Iss. 3, pp. 198-203
Closed Access
Sebastian Ochsenreither, M. de Bucourt, Oliver Zeitz, et al.
Trillium Krebsmedizin (2024) Vol. 33, Iss. 3, pp. 198-203
Closed Access
Impact of the COVID-19 Pandemic on Allergy Indicators in Adults: A Retrospective Study from 2018 to 2023
Junkang Chen, Yena Gu, Zhexuan Yu, et al.
Research Square (Research Square) (2024)
Open Access
Junkang Chen, Yena Gu, Zhexuan Yu, et al.
Research Square (Research Square) (2024)
Open Access
Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors
Florentia Dimitriou, Marlana Orloff, Erica C. Koch Hein, et al.
European Journal of Cancer (2024) Vol. 214, pp. 115161-115161
Open Access
Florentia Dimitriou, Marlana Orloff, Erica C. Koch Hein, et al.
European Journal of Cancer (2024) Vol. 214, pp. 115161-115161
Open Access
A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma – Results of systematic literature research
Teresa Amaral, Lena Nanz, Lina María Serna‐Higuita, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115160-115160
Open Access
Teresa Amaral, Lena Nanz, Lina María Serna‐Higuita, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115160-115160
Open Access
